BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8745244)

  • 1. Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells.
    Chariot P; Le Maguet F; Authier FJ; Labes D; Poron F; Gherardi R
    Neuropathol Appl Neurobiol; 1995 Dec; 21(6):540-7. PubMed ID: 8745244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits.
    Yerroum M; Pham-Dang C; Authier FJ; Monnet I; Gherardi R; Chariot P
    Acta Neuropathol; 2000 Jul; 100(1):82-6. PubMed ID: 10912924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P; Monnet I; Gherardi R
    Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy.
    Chariot P; Bonne G; Authier FJ; Marsac C; Gherardi R
    J Neurol Sci; 1994 Sep; 125(2):190-3. PubMed ID: 7807166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The length of cytochrome c oxidase-negative segments in muscle fibres in patients with mtDNA myopathy.
    Elson JL; Samuels DC; Johnson MA; Turnbull DM; Chinnery PF
    Neuromuscul Disord; 2002 Nov; 12(9):858-64. PubMed ID: 12398838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV or zidovudine myopathy?
    Gherardi R; Chariot P
    Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
    [No Abstract]   [Full Text] [Related]  

  • 7. Respiratory chain dysfunction in perifascicular muscle fibres in patients with dermatomyositis is associated with mitochondrial DNA depletion.
    Hedberg-Oldfors C; Lindgren U; Visuttijai K; Lööf D; Roos S; Thomsen C; Oldfors A
    Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12841. PubMed ID: 35894812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical progression of mitochondrial myopathy is associated with the random accumulation of cytochrome c oxidase negative skeletal muscle fibres.
    Chinnery PF; Howel D; Turnbull DM; Johnson MA
    J Neurol Sci; 2003 Jul; 211(1-2):63-6. PubMed ID: 12767499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome c oxidase-intermediate fibres: importance in understanding the pathogenesis and treatment of mitochondrial myopathy.
    Murphy JL; Ratnaike TE; Shang E; Falkous G; Blakely EL; Alston CL; Taivassalo T; Haller RG; Taylor RW; Turnbull DM
    Neuromuscul Disord; 2012 Aug; 22(8):690-8. PubMed ID: 22647770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome c oxidase deficient muscle fibres: substantial variation in their proportions within skeletal muscles from patients with mitochondrial myopathy.
    Barron MJ; Chinnery PF; Howel D; Blakely EL; Schaefer AM; Taylor RW; Turnbull DM
    Neuromuscul Disord; 2005 Nov; 15(11):768-74. PubMed ID: 16198107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AZT-induced mitochondrial myopathy.
    Tomelleri G; Tonin P; Spadaro M; Tilia G; Orrico D; Barelli A; Bonetti B; Monaco S; Salviati A; Morocutti C
    Ital J Neurol Sci; 1992 Dec; 13(9):723-8. PubMed ID: 1336487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy.
    Chariot P; Gherardi R
    Neuromuscul Disord; 1991; 1(5):357-63. PubMed ID: 1668320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochemistry and immunocytochemistry of cytochrome-c oxidase at electron microscope level.
    Müller-Höcker J; Schäfer S
    Methods Enzymol; 1996; 264():540-55. PubMed ID: 8965725
    [No Abstract]   [Full Text] [Related]  

  • 14. Ageing muscle: clonal expansions of mitochondrial DNA point mutations and deletions cause focal impairment of mitochondrial function.
    Fayet G; Jansson M; Sternberg D; Moslemi AR; Blondy P; Lombès A; Fardeau M; Oldfors A
    Neuromuscul Disord; 2002 Jun; 12(5):484-93. PubMed ID: 12031622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice.
    Lebrecht D; Deveaud C; Beauvoit B; Bonnet J; Kirschner J; Walker UA
    Arthritis Rheum; 2008 Jan; 58(1):318-26. PubMed ID: 18163507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle involvement in HIV-infected patients.
    Gherardi RK
    Neuropathol Appl Neurobiol; 1994 Jun; 20(3):232-7. PubMed ID: 7936072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular aggregates and partial cytochrome c oxidase deficiency in skeletal muscle of patients with AIDS treated with zidovudine.
    Chariot P; Benbrik E; Schaeffer A; Gherardi R
    Acta Neuropathol; 1993; 85(4):431-6. PubMed ID: 8386898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of myopathy with large-scale mitochondrial DNA duplications and deletions: which is pathogenic?
    Manfredi G; Vu T; Bonilla E; Schon EA; DiMauro S; Arnaudo E; Zhang L; Rowland LP; Hirano M
    Ann Neurol; 1997 Aug; 42(2):180-8. PubMed ID: 9266727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies.
    Chariot P; Ruet E; Authier FJ; Labes D; Poron F; Gherardi R
    Acta Neuropathol; 1996; 91(5):530-6. PubMed ID: 8740235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic yield muscle biopsy in patients with clinical evidence of mitochondrial cytopathy.
    Rollins S; Prayson RA; McMahon JT; Cohen BH
    Am J Clin Pathol; 2001 Sep; 116(3):326-30. PubMed ID: 11554158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.